560 related articles for article (PubMed ID: 10480130)
1. Residual activity of Bacillus thuringiensis serovars medellin and jegathesan on Culex pipiens and Aedes aegypti larvae.
Thiéry I; Fouque F; Gaven B; Lagneau C
J Am Mosq Control Assoc; 1999 Sep; 15(3):371-9. PubMed ID: 10480130
[TBL] [Abstract][Full Text] [Related]
2. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species.
Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD
J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Bacillus sphaericus and Bacillus thuringiensis var. israelensis for control of Culex pipiens and floodwater Aedes larvae in Iowa.
Berry WJ; Novak MG; Khounlo S; Rowley WA; Melchior GL
J Am Mosq Control Assoc; 1987 Dec; 3(4):579-82. PubMed ID: 3504943
[TBL] [Abstract][Full Text] [Related]
4. A new serovar of Bacillus thuringiensis possessing 28a28c flagellar antigenic structure: Bacillus thuringiensis serovar jegathesan, selectively toxic against mosquito larvae.
Seleena P; Lee HL; Lecadet MM
J Am Mosq Control Assoc; 1995 Dec; 11(4):471-3. PubMed ID: 8825511
[TBL] [Abstract][Full Text] [Related]
5. Bacterial control of mosquito larvae: investigation of stability of Bacillus thuringiensis var. israelensis and Bacillus sphaericus standard powders.
Thiery I; Hamon S
J Am Mosq Control Assoc; 1998 Dec; 14(4):472-6. PubMed ID: 10084145
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the activity of Bacillus thuringiensis var. israelensis treatments.
Becker N; Zgomba M; Ludwig M; Petric D; Rettich F
J Am Mosq Control Assoc; 1992 Sep; 8(3):285-9. PubMed ID: 1357088
[TBL] [Abstract][Full Text] [Related]
7. An isolate of Bacillus circulans toxic to mosquito larvae.
Darriet F; Hougard JM
J Am Mosq Control Assoc; 2002 Mar; 18(1):65-7. PubMed ID: 11998934
[TBL] [Abstract][Full Text] [Related]
8. Laboratory and field evaluation of Bacillus thuringiensis and B. sphaericus against mosquito larvae.
Baruah I; Das SC
J Commun Dis; 1994 Jun; 26(2):82-7. PubMed ID: 7989680
[TBL] [Abstract][Full Text] [Related]
9. Integrated management of waste tire mosquitoes utilizing Mesocyclops longisetus (Copepoda: Cyclopidae), Bacillus thuringiensis var. israelensis, Bacillus sphaericus, and methoprene.
Tietze NS; Hester PG; Shaffer KR; Prescott SJ; Schreiber ET
J Am Mosq Control Assoc; 1994 Sep; 10(3):363-73. PubMed ID: 7807078
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Czechoslovak and Soviet Bacillus thuringiensis (serotype H-14) formulations against mosquito larvae.
Rettich F
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):53-63. PubMed ID: 2883232
[TBL] [Abstract][Full Text] [Related]
11. Comparative delta-endotoxins of Bacillus thuringiensis against mosquito vectors (Aedes aegypti and Culex pipiens).
Lonc E; Kucińska J; Rydzanicz K
Acta Microbiol Pol; 2003; 52(3):293-300. PubMed ID: 14743982
[TBL] [Abstract][Full Text] [Related]
12. Host range and selected factors influencing the mosquito larvicidal activity of the PG-14 isolate of Bacillus thuringiensis var. morrisoni.
Lacey LA; Lacey CM; Padua LE
J Am Mosq Control Assoc; 1988 Mar; 4(1):39-43. PubMed ID: 3193097
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of Bacillus thuringiensis Cry4Ba and Cyt2Aa2 in Escherichia coli revealed high synergism against Aedes aegypti and Culex quinquefasciatus larvae.
Promdonkoy B; Promdonkoy P; Panyim S
FEMS Microbiol Lett; 2005 Nov; 252(1):121-6. PubMed ID: 16168580
[TBL] [Abstract][Full Text] [Related]
14. Protocol for the introduction of new Bacillus thuringiensis Israelensis products into the routine mosquito control program in Germany.
Becker N; Rettich F
J Am Mosq Control Assoc; 1994 Dec; 10(4):527-33. PubMed ID: 7707059
[TBL] [Abstract][Full Text] [Related]
15. Effect of inactivation by sunlight on the larvicidal activities of mosquitocidal Bacillus thuringiensis H-14 isolates from Nigerian soils.
Obeta JA
J Commun Dis; 1996 Jun; 28(2):94-100. PubMed ID: 8810143
[TBL] [Abstract][Full Text] [Related]
16. Laboratory and field evaluation of Teknar HP-D, a biolarvicidal formulation of Bacillus thuringiensis ssp. israelensis, against mosquito vectors.
Gunasekaran K; Doss PS; Vaidyanathan K
Acta Trop; 2004 Oct; 92(2):109-18. PubMed ID: 15350862
[TBL] [Abstract][Full Text] [Related]
17. Combination of Mesocyclops thermocyclopoides and Bacillus thuringiensis var. israelensis: a better approach for the control of Aedes aegypti larvae in water containers.
Chansang UR; Bhumiratana A; Kittayapong P
J Vector Ecol; 2004 Dec; 29(2):218-26. PubMed ID: 15707281
[TBL] [Abstract][Full Text] [Related]
18. Laboratory and field efficacy of Bacillus thuringiensis var. Israelensis and Bacillus sphaericus against Anopheles gambiae s.l. and Culex quinquefasciatus in Ouagadougou, Burkina Faso.
Majori G; Ali A; Sabatinelli G
J Am Mosq Control Assoc; 1987 Mar; 3(1):20-5. PubMed ID: 3504891
[TBL] [Abstract][Full Text] [Related]
19. Optimization of spray-drying conditions for the large-scale preparation of Bacillus thuringiensis var. israelensis after downstream processing.
Prabakaran G; Hoti SL
Biotechnol Bioeng; 2008 May; 100(1):103-7. PubMed ID: 18023058
[TBL] [Abstract][Full Text] [Related]
20. Protozoan-enhanced toxicity of Bacillus thuringiensis var. israelensis delta-endotoxin against Aedes aegypti larvae.
Manasherob R; Ben-Dov E; Zaritsky A; Barak Z
J Invertebr Pathol; 1994 May; 63(3):244-8. PubMed ID: 8021522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
